EPIRUBICIN ACTAVIS
2MG/ML INJ SOL 1X5ML I
| SÚKL code | 0224648 |
|---|---|
| Name of the product | EPIRUBICIN ACTAVIS |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | EPIRUBICIN ACTAVIS |
| Supplement | 2MG/ML INJ SOL 1X5ML I |
| Strenght | 2MG/ML |
| Pharmaceutical form | Solution for injection |
| Package | 1X5ML I |
| Route | Intravenous/intravesical use |
| Language of the pack | Czech |
| Wrap type | Vial |
| Legal status | na lékařský předpis |
| Active substance | EPIRUBICIN HYDROCHLORIDE (EPIRUBICINI HYDROCHLORIDUM) |
| ATC group | L01DB03 |
| ATC group name | EPIRUBICIN |
Marketing authorisation information
| Registration Number | 44/ 108/08-C |
|---|---|
| Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Reference member state |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 31. 12. 2022 |
| MA Holder | Actavis Group PTC ehf., Hafnarfjördur |
| MA Holder country | ISLAND |
| Actual MA holder | Teva B.V., Haarlem |
| Actual MA holder country | NIZOZEMSKO |
cz